1. Home
  2. ICUI vs IPGP Comparison

ICUI vs IPGP Comparison

Compare ICUI & IPGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUI
  • IPGP
  • Stock Information
  • Founded
  • ICUI 1984
  • IPGP 1990
  • Country
  • ICUI United States
  • IPGP United States
  • Employees
  • ICUI N/A
  • IPGP N/A
  • Industry
  • ICUI Medical/Dental Instruments
  • IPGP Semiconductors
  • Sector
  • ICUI Health Care
  • IPGP Technology
  • Exchange
  • ICUI Nasdaq
  • IPGP Nasdaq
  • Market Cap
  • ICUI 3.0B
  • IPGP 3.2B
  • IPO Year
  • ICUI 1992
  • IPGP 2006
  • Fundamental
  • Price
  • ICUI $128.18
  • IPGP $82.16
  • Analyst Decision
  • ICUI Buy
  • IPGP Buy
  • Analyst Count
  • ICUI 6
  • IPGP 7
  • Target Price
  • ICUI $185.00
  • IPGP $77.60
  • AVG Volume (30 Days)
  • ICUI 371.2K
  • IPGP 232.1K
  • Earning Date
  • ICUI 08-07-2025
  • IPGP 08-05-2025
  • Dividend Yield
  • ICUI N/A
  • IPGP N/A
  • EPS Growth
  • ICUI N/A
  • IPGP N/A
  • EPS
  • ICUI N/A
  • IPGP N/A
  • Revenue
  • ICUI $2,372,504,000.00
  • IPGP $945,994,000.00
  • Revenue This Year
  • ICUI N/A
  • IPGP N/A
  • Revenue Next Year
  • ICUI N/A
  • IPGP $7.66
  • P/E Ratio
  • ICUI N/A
  • IPGP N/A
  • Revenue Growth
  • ICUI 2.96
  • IPGP N/A
  • 52 Week Low
  • ICUI $107.00
  • IPGP $48.59
  • 52 Week High
  • ICUI $196.26
  • IPGP $88.50
  • Technical
  • Relative Strength Index (RSI)
  • ICUI 55.51
  • IPGP 63.52
  • Support Level
  • ICUI $120.95
  • IPGP $74.36
  • Resistance Level
  • ICUI $125.02
  • IPGP $79.87
  • Average True Range (ATR)
  • ICUI 5.30
  • IPGP 2.93
  • MACD
  • ICUI 1.12
  • IPGP 0.13
  • Stochastic Oscillator
  • ICUI 82.93
  • IPGP 82.71

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

About IPGP IPG Photonics Corporation

IPG Photonics Corp is a vertically integrated developer and manufacturer of high-performance fiber lasers, fiber amplifiers, and diode lasers, which are used in diverse applications in the manufacturing, automotive, industrial, aerospace, semiconductor, and consumer end markets. The company operates in one segment which involves the design, development, production and distribution of fiber lasers, laser and non-laser systems, fiber amplifiers, and related optical components. A large majority of the firm's revenue is derived from materials processing applications for fiber lasers, including cutting and welding, marking and engraving, and micro-processing. The company generates a majority of its revenue from North America and also has its presence in China, Japan, Germany, and other markets.

Share on Social Networks: